Changes in Th1/Th2 cytokine balance in Graves’ desease

被引:0
|
作者
Tomaž Kocjan
Branka Wraber
Urška Repnik
Sergej Hojker
机构
[1] Dept. of Endocrinology and Diabetes,
[2] Medical Centre Ljubljana,undefined
[3] Zaloška 7,undefined
[4] 1525 Ljubljana,undefined
[5] Slovenia,undefined
[6] Institute of Microbiology and Immunology,undefined
[7] Medical Faculty,undefined
[8] University of Ljubljana,undefined
[9] Zaloška 4,undefined
[10] 1000 Ljubljana,undefined
[11] Slovenia,undefined
[12] Dept. of Nuclear Medicine,undefined
[13] Medical Centre Ljubljana,undefined
[14] Zaloška 7,undefined
[15] 1525 Ljubljana,undefined
[16] Slovenia,undefined
来源
Pflügers Archiv - European Journal of Physiology | 2000年 / 440卷
关键词
Key words Graves’ disease; Th1/Th2 cytokine balance; Mononuclear cells; Ionomycin; Phorbol myristate acetate;
D O I
暂无
中图分类号
学科分类号
摘要
Graves’ disease (GD) is characterised by hyperthyroidism, caused by stimulatory thyrotropin receptor (TSHR) antibodies. Recent research shows that an important factor in the pathogenesis of autoimmune diseases is the change in the balance between Th1 cytokines, which promote cell mediated immunity, and Th2 cytokines, which promote humoral immunity. There are contradictory data about this balance shift in GD. Our objective was to determine the Th1/Th2 cytokine balance shift in patients with newly diagnosed GD, when compared to the same balance in healthy controls. We isolated mononuclear cells (MNC) from the peripheral blood of healthy donors and from patients with newly diagnosed GD before treatment. The MNC were activated with ionomycin in combination with phorbol 12-myristate 13-acetate (PMA). After 40-hour incubation, the concentrations of the cytokines produced (IFN-γ, IL-4, IL-10, IL-12) in the culture supernatants were measured by ELISA (Endogen, USA). The MNC cultures from patients with GD produced significantly less IL-12 and significantly more IL-10 and IL-4 than MNC cultures from healthy controls. All calculated ratios of Th1 against Th2 cytokines in MNC cultures from patients with GD were significantly lower than in MNC cultures from healthy controls. Our results show a systemic shift of cytokine production in patients with GD toward the Th2 cytokine response, thus confirming the key role of TSHR antibodies and humoral immunity in the pathogenesis of GD.
引用
收藏
页码:R094 / R095
相关论文
共 50 条
  • [1] Changes in Th1/Th2 cytokine balance in Graves' disease
    Kocjan, T
    Wraber, B
    Repnik, U
    Hojker, S
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2000, 440 (05): : R94 - R95
  • [2] Th1/Th2 cytokine balance in arthritis
    Miossec, P
    van den Berg, W
    ARTHRITIS AND RHEUMATISM, 1997, 40 (12): : 2105 - 2115
  • [3] Effects of histamine on Th1/Th2 cytokine balance
    Packard, KA
    Khan, MM
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2003, 3 (07) : 909 - 920
  • [4] Histamine shifts TH1/TH2 cytokine balance
    Osna, N
    Elliot, K
    Khan, MM
    FASEB JOURNAL, 2000, 14 (06): : A1244 - A1244
  • [5] The Effect of Safranal on Th1/Th2 Cytokine Balance
    Feyzi, Reza
    Boskabady, Mohammad Hossein
    Tamijani, Seyedeh Masoumeh Seyed Hosseini
    Rafatpanah, Houshang
    Rezaei, Seyed Abdolrahim
    IRANIAN JOURNAL OF IMMUNOLOGY, 2016, 13 (04) : 263 - 273
  • [6] Th1/Th2 cytokine balance in severe sepsis
    Jovanovic, K
    Surbatovic, M
    Filipovic, N
    INTENSIVE CARE MEDICINE, 2002, 28 : S36 - S36
  • [7] Disturbed Th1 and Th2 balance in patients with Graves' disease
    Eshaghkhani, Yeganeh
    Sanati, Mohammad H.
    Nakhjavani, Manouchehr
    Safari, Reza
    Khajavi, Alireza
    Ataei, Mitra
    Jadali, Zohreh
    MINERVA ENDOCRINOLOGICA, 2016, 41 (01) : 28 - 34
  • [8] Reproductive Hormones in the Control of Th1/Th2 Cytokine Balance
    E. M. Kuklina
    S. V. Shirshev
    Biology Bulletin, 2005, 32 : 221 - 228
  • [9] Reproductive hormones in the control of Th1/Th2 cytokine balance
    Kuklina, EM
    Shirshev, SV
    BIOLOGY BULLETIN, 2005, 32 (03) : 221 - 228
  • [10] Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2)
    Phenekos, C
    Vryonidou, A
    Gritzapis, AD
    Baxevanis, CN
    Goula, M
    Papamichail, M
    NEUROIMMUNOMODULATION, 2004, 11 (04) : 209 - 213